Medication Monitor



Generic Name (Trade Name—Company)
Notes
January 7, 2016

0.9% sodium chloride, 70% dextrose

(No trade names—Baxter International)
Two lots of I.V. solutions may contain particulate matter

Baxter International is voluntarily recalling two lots (#C980227, #C985150) of I.V. solutions to the hospital/end user level after a costumer complaint about particulate matter, which was determined to be an insect.

The I.V. solutions are 0.9% sodium chloride injection (250 mL Viaflex plastic container), a source of water and electrolytes and also a priming solution in hemodialysis procedures; and 70% dextrose injection (2000 mL), a source of calories and water for hydration. 

The matter was identified before patient administration, and there have been no adverse events associated with this issue reported to Baxter to date.

Injecting a product containing particulate matter, in the absence of in-line filtration, may result in blockage of blood vessels, which can result in stroke, heart attack, or damage to other organs such as the kidney or liver. There is also the possibility of allergic reactions, local irritation, and inflammation in tissues and organs.

The recalled lots were distributed to customers and distributors in the United States between June 6, 2015, and December 16, 2015. Recalled product should be returned to Baxter for credit by contacting Baxter Healthcare Center for Service at 888-229-0001, Monday through Friday, between the hours of 7 am and 6 pm, Central Time.